Business
McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day
IRVING, Texas, September 23, 2025--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company’s multi-year strategic priorities, growth strategies, and long-term business outlook.
About this update from Mckesson Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/d309dc4c0a12377e8e0b33f27a4ec773"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kdvyRSka6V4stCxoca68mQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d309dc4c0a12377e8e0b33f27a4ec773","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ljQAEpmV7gIWcNN29Bzh9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/d309dc4c0a12377e8e0b33f27a4ec773","width":1024,"height":512}},"lazy":false},{"type":"text","content":"IRVING, Texas, September 23, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company’s multi-year strategic priorities, growth strategies, and long-term business outlook.","length":298,"tagName":"p"},{"type":"text","content":"The Investor Day event will showcase how McKesson continues to accelerate long-term growth and deliver sustained value creation:","length":128,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Executing strategic priorities: Demonstrating significant progress, focusing on people and culture, strengthening North American Pharmaceutical distribution, modernizing and accelerating the portfolio, and expanding oncology, multispecialty, and biopharma services platforms.","length":275,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Advancing portfolio optimization: Providing an update on portfolio developments, including the Medical-Surgical separation.","length":123,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reaffirming growth pillars: Highlighting McKesson’s differentiated assets and capabilities across oncology, multispecialty, and biopharma services, positioning the company to lead in high-growth markets and improve patient health outcomes.","length":239,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Introducing a new organizational structure: As announced on September 18, 2025, the new structure reflects McKesson’s sharpened focus on accelerating growth, enhancing transparency, ...